Quotes 5-day view End-of-day quote Tokyo Stock Exchange
11/20/2020
11/24/2020
11/25/2020
11/26/2020
11/27/2020
Date
4064
4193
4216
4156
4132
Last
2732000
2680700
2174100
1930200
2409800
Volume
-4.22% +3.17% +0.55% -1.42% -0.58% Change
Sales 2021
608 B 5 845 M 5 845 M
Net income 2021
70 966 M 682 M 682 M
Net Debt 2021
71 714 M 689 M 689 M
P/E ratio 2021
44,1x
Yield 2021
0,68%
Sales 2022
672 B 6 461 M 6 461 M
Net income 2022
94 052 M 904 M 904 M
Net Debt 2022
44 625 M 429 M 429 M
P/E ratio 2022
33,7x
Yield 2022
0,74%
Capitalization
3 122 B 29 941 M 29 998 M
EV / Sales 2021
5,25x
EV / Sales 2022
4,71x
Nbr of Employees
26 438
Free-Float
95,6%
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (55.7%);
- medical products for hospitals (27.2%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments...
Notations Surperformance© of Terumo Corporation
Trading Rating : Investor Rating :
All news about TERUMO CORPORATION
News in other languages on TERUMO CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends TERUMO CORPORATION
Short Term Mid-Term Long Term Trends Neutral Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
14
Average target price
4 610,77 JPY
Last Close Price
4 132,00 JPY
Spread / Highest target
30,7%
Spread / Average Target
11,6%
Spread / Lowest Target
-8,03%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
